Plasmablastic Lymphoma: Characterization of Tumor Microenvironment by CD163 and PD1 Immunohistochemistry

被引：0
|
作者：
Ahn, Janice
Rosado, Flavia G.
Sohani, Aliyah R.
Vos, Jeffrey
机构：
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
LABORATORY INVESTIGATION | 2016年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1325
引用
收藏
页码：333A / 333A
页数：1
相关论文
共 50 条
  • [1] Plasmablastic Lymphoma: Characterization of Tumor Microenvironment by CD163 and PD1 Immunohistochemistry
    Ahn, Janice
    Rosado, Flavia G.
    Sohani, Aliyah R.
    Vos, Jeffrey
    MODERN PATHOLOGY, 2016, 29 : 333A - 333A
  • [2] Plasmablastic Lymphomas: Characterization of Tumor Microenvironment Using CD163 and PD-1 Immunohistochemistry
    Ahn, Janice S.
    Al-Habib, Ali
    Vos, Jeffrey A.
    Sohani, Aliyah R.
    Barboza-Quintana, Oralia
    Flores, Juan P.
    Wen, Sijin
    Rosado, Flavia G.
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2020, 50 (02): : 213 - 218
  • [3] Epstein Barr Virus-Positive Classical Hodgkin Lymphoma: Characterization of Microenvironment Using CD 163 and PD-1 Expression by Immunohistochemistry
    Al-Habib, Ali
    Ahn, Janice
    Okal, Ryan
    Vos, Jeffrey
    Rosado, Flavia G.
    LABORATORY INVESTIGATION, 2016, 96 : 334A - 334A
  • [4] Epstein Barr Virus-Positive Classical Hodgkin Lymphoma: Characterization of Microenvironment Using CD 163 and PD-1 Expression by Immunohistochemistry
    Al-Habib, Ali
    Ahn, Janice
    Okal, Ryan
    Vos, Jeffrey
    Rosado, Flavia G.
    MODERN PATHOLOGY, 2016, 29 : 334A - 334A
  • [5] Prognostic Value of Tumor Associated Macrophage Markers CD163 and CD68 Immunohistochemistry in Classical Hodgkin Lymphoma
    Rashed, Reham A.
    Zaki, Mohamed A. M.
    Mohamed, Nahed A. W.
    Mansou, Osman M.
    El Refaey, Fatma A. H.
    CLINICAL LABORATORY, 2021, 67 (05) : 1257 - 1265
  • [6] Function of CD163, a macrophage scavenger receptor, in tumor microenvironment of sarcoma
    Fujiwara, Yukio
    Shiraishi, Daisukie
    Horlad, Hasita
    Komohara, Yoshihiro
    CANCER SCIENCE, 2018, 109 : 935 - 935
  • [7] PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation
    Rosado, Flavia G.
    Coberly, Jared
    Gupta, Arjun
    John, George
    Naina, Harris
    Koduru, Prasad
    Chen, Weina
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (02): : 174 - 181
  • [8] CD163 Immunohistochemistry Is Superior to CD68 in Predicting Outcome in Classical Hodgkin Lymphoma
    Klein, Jonathan L.
    Nguyen, TuDung T.
    Bien-Willner, Gabriel A.
    Chen, Ling
    Foyil, Kelley V.
    Bartlett, Nancy L.
    Duncavage, Eric J.
    Hassan, Anjum
    Frater, John L.
    Kreisel, Friederike
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (03) : 381 - 387
  • [9] Characterization of the expression of murine CD163
    Fischer-Riepe, L.
    Holzinger, D.
    Wolf, M.
    Fischer, J.
    Rosenbauer, F.
    Roth, J.
    Barczyk-Kahlert, K.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 : 24 - 24
  • [10] The Prognostic Impact of Tumor Microenvironment and Checkpoint Blockade-Associated Molecules (PD-1, PD-L1, CD163 and CD14) in Nodal Diffuse Large B-cell Lymphoma, NOS
    Atmis, Omer
    Nese, Nalan
    Aydogdu, Ismet
    Alaca, Ilknur
    Mavili, Hanife Seda
    Isisag, Aydin
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (02) : 340 - 345
12345